These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34037220)

  • 1. Long-term survival following upgrade compared with de novo cardiac resynchronization therapy implantation: a single-centre, high-volume experience.
    Schwertner WR; Behon A; Merkel ED; Tokodi M; Kovács A; Zima E; Osztheimer I; Molnár L; Király Á; Papp R; Gellér L; Kuthi L; Veres B; Kosztin A; Merkely B
    Europace; 2021 Aug; 23(8):1310-1318. PubMed ID: 34037220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upgrade from implantable cardioverter-defibrillator vs. de novo implantation of cardiac resynchronization therapy: long-term outcomes.
    Jędrzejczyk-Patej E; Mazurek M; Kotalczyk A; Kowalska W; Konieczny-Kozielska A; Kozielski J; Podolecki T; Szulik M; Sokal A; Kowalski O; Kalarus Z; Średniawa B; Lenarczyk R
    Europace; 2021 Jan; 23(1):113-122. PubMed ID: 33257952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcome after upgrade to cardiac resynchronization therapy: A propensity score-matched analysis.
    Trenson S; Voros G; Martens P; Ingelaere S; Betschart P; Voigt JU; Dupont M; Breitenstein A; Steffel J; Willems R; Ruschitzka F; Mullens W; Winnik S; Vandenberk B
    Eur J Heart Fail; 2024 Feb; 26(2):511-520. PubMed ID: 37905357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome in patients undergoing upgrade to cardiac resynchronization therapy: predictors of outcome after upgrade to CRT.
    Kosiuk J; Krause M; Doering M; Weber A; Breithardt OA; Dinov B; Darma A; Lucas J; Muessigbrodt A; Bode K; Kuehl M; Dagres N; Hindricks G; Bollmann A; Richter S
    Heart Vessels; 2020 Jan; 35(1):104-109. PubMed ID: 31227877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence, predictors, and procedural results of upgrade to resynchronization therapy: the RAFT upgrade substudy.
    Essebag V; Joza J; Birnie DH; Sapp JL; Sterns LD; Philippon F; Yee R; Crystal E; Kus T; Rinne C; Healey JS; Sami M; Thibault B; Exner DV; Coutu B; Simpson CS; Wulffhart Z; Yetisir E; Wells G; Tang AS
    Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):152-8. PubMed ID: 25417892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Upgrade Versus De Novo Cardiac Resynchronization Therapy on Clinical Response and Long-Term Survival: Results from a Multicenter Study.
    Vamos M; Erath JW; Bari Z; Vagany D; Linzbach SP; Burmistrava T; Israel CW; Duray GZ; Hohnloser SH
    Circ Arrhythm Electrophysiol; 2017 Feb; 10(2):e004471. PubMed ID: 28202628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of left ventricular lead upgrade vs continued medical care among patients eligible for cardiac resynchronization therapy at the time of defibrillator generator replacement: Predictors of left ventricular lead upgrade and associations with long-term outcomes.
    Hyman MC; Bao H; Curtis JP; Minges K; Schaller RD; Birgersdotter-Green U; Marchlinski FE; Hsu JC
    Heart Rhythm; 2020 Nov; 17(11):1878-1886. PubMed ID: 32497762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Analysis of Procedural Outcomes and Complications Between De Novo and Upgraded Cardiac Resynchronization Therapy.
    Nemer DM; Patel DR; Madden RA; Wilkoff BL; Rickard JW; Tarakji KG; Varma N; Hussein AA; Wazni OM; Kanj M; Baranowski B; Cantillon DJ
    JACC Clin Electrophysiol; 2021 Jan; 7(1):62-72. PubMed ID: 33478714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block.
    Biton Y; Zareba W; Goldenberg I; Klein H; McNitt S; Polonsky B; Moss AJ; Kutyifa V;
    J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26124205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applicability of a risk score for prediction of the long-term benefit of the implantable cardioverter defibrillator in patients receiving cardiac resynchronization therapy.
    Barra S; Looi KL; Gajendragadkar PR; Khan FZ; Virdee M; Agarwal S
    Europace; 2016 Aug; 18(8):1187-93. PubMed ID: 26566940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of
    Zandi Z; Eslami M; Kamali F; Teimouri-Jervekani Z; Taherpour M; Mollazadeh R; Haghjoo M; Fazelifar AF; Alizadeh A; Madadi S; Hosseini Selki Sar S; Emkanjoo Z
    Acta Cardiol; 2024 May; 79(3):338-343. PubMed ID: 38032242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The European Society of Cardiology Cardiac Resynchronization Therapy Survey II: A comparison of cardiac resynchronization therapy implantation practice in Europe and France.
    Galand V; Linde C; Lellouche N; Mansourati J; Deharo JC; Sagnol P; Da Costa A; Horvilleur J; Defaye P; Boveda S; Steinbach M; Bru P; Rumeau P; Beard T; Younsi S; Dickstein K; Normand C; Leclercq C
    Arch Cardiovasc Dis; 2019 Nov; 112(11):713-722. PubMed ID: 31706879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effectiveness of cardiac resynchronization therapy with an implantable cardioverter-defibrillator versus defibrillator therapy alone: a cohort study.
    Masoudi FA; Mi X; Curtis LH; Peterson PN; Curtis JP; Fonarow GC; Hammill SC; Heidenreich PA; Al-Khatib SM; Piccini JP; Qualls LG; Hernandez AF
    Ann Intern Med; 2014 May; 160(9):603-11. PubMed ID: 24798523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De novo implantation vs. upgrade cardiac resynchronization therapy: a systematic review and meta-analysis.
    Kosztin A; Vamos M; Aradi D; Schwertner WR; Kovacs A; Nagy KV; Zima E; Geller L; Duray GZ; Kutyifa V; Merkely B
    Heart Fail Rev; 2018 Jan; 23(1):15-26. PubMed ID: 29047028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of
    Stassen J; Scherrenberg M; Dilling-Boer D; Vijgen J; Koopman P; Schurmans J; Herbots L; Verwerft J; Schroyens M; Timmermans P
    Acta Cardiol; 2021 Nov; 76(9):993-1000. PubMed ID: 33432875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adding the implantable cardioverter-defibrillator to cardiac resynchronization therapy is associated with improved long-term survival in ischaemic, but not in non-ischaemic cardiomyopathy.
    Witt CT; Kronborg MB; Nohr EA; Mortensen PT; Gerdes C; Jensen HK; Nielsen JC
    Europace; 2016 Mar; 18(3):413-9. PubMed ID: 26378089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-life outcome of implantable cardioverter-defibrillator and cardiac resynchronization defibrillator replacement/upgrade in a contemporary population: observations from the multicentre DECODE registry.
    Biffi M; Ammendola E; Menardi E; Parisi Q; Narducci ML; De Filippo P; Manzo M; Stabile G; Potenza DR; Zanon F; Quartieri F; Rillo M; Saporito D; Zacà V; Berisso MZ; Bertini M; Tumietto F; Malacrida M; Diemberger I
    Europace; 2019 Oct; 21(10):1527-1536. PubMed ID: 31209482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term clinical outcomes after upgrade to resynchronization therapy: A propensity score-matched analysis.
    Brandão M; Almeida JG; Fonseca P; Monteiro J; Santos E; Rosas F; Nogueira Ribeiro J; Oliveira M; Gonçalves H; Primo J; Fontes-Carvalho R
    Heart Rhythm O2; 2021 Dec; 2(6Part B):671-679. PubMed ID: 34988515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Characteristics and Outcomes of Older Cardiac Resynchronization Therapy Recipients Using a Pacemaker versus a Defibrillator.
    Munir MB; Althouse AD; Rijal S; Shah MB; Abu Daya H; Adelstein E; Saba S
    J Cardiovasc Electrophysiol; 2016 Jun; 27(6):730-4. PubMed ID: 26856440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes of upgrade to versus de novo cardiac resynchronization therapy in mild heart failure patients with atrioventricular block.
    Kanai M; Yagishita D; Shoda M; Ejima K; Hagiwara N
    J Cardiol; 2022 Jan; 79(1):6-14. PubMed ID: 34426046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.